Antimicrobial Peptides for Vibrio Control Without Antibiotic Resistance
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The increasing concern of antibiotic-resistant bacteria in foodborne pathogens, particularly Vibrios, poses a significant threat to food safety and human health due to the limited effectiveness of current antibiotic treatments and the risk of resistance development.
Innovation Solution
Development of antimicrobial peptides, such as BMAP-27A, BMAP-27B, SMAP-29B, SMAP-29D, BMAP-24, and B22, which are effective against Gram-negative bacteria including Vibrios, by targeting and killing these pathogens while minimizing cytotoxicity to human cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antibiotics are used to treat Vibrio infections in fish and shellfish, then bacterial growth is inhibited, but antibiotic-resistant bacteria develop and spread
Solution Approach 1:
The patent changes the fundamental parameter of the antimicrobial agent from conventional antibiotics to antimicrobial peptides (AMPs). These peptides exhibit different mechanisms of action, including membrane disruption and pore formation, which do not rely on the same resistance mechanisms as antibiotics. The peptide sequences and structures are optimized to maintain high efficacy against Vibrio species while avoiding the selection pressure that drives antibiotic resistance.
Solution Approach 2:
The patent employs naturally derived antimicrobial peptides that can be rapidly synthesized and degraded by proteolytic enzymes in the environment. This short-lived characteristic prevents long-term accumulation and selective pressure for resistance, as the peptides are quickly broken down into amino acids after use, unlike persistent antibiotics that continue to exert selective pressure.
2Reliability
If conventional antibiotics are used for foodborne pathogen control, then bacterial infection is treated, but resistance genes transfer to human pathogens
Solution Approach 1:
The patent introduces antimicrobial peptides as an intermediary substance that bridges the gap between food safety requirements and the prevention of resistance gene transfer. These peptides provide effective bacterial control without creating the selective pressure that drives horizontal gene transfer of resistance genes from animal to human pathogens.
3Productivity
If antimicrobial peptides are used to kill Gram-negative bacteria, then bacterial loading is reduced, but peptide stability and efficacy must be maintained
Solution Approach 1:
The patent employs composite peptide structures that combine multiple functional features: hydrophobic regions for membrane insertion, hydrophilic regions for solubility, and specific amino acid sequences that enhance stability against proteolytic degradation. Some peptides are designed as cyclic structures or with modified side chains that resist enzymatic breakdown while maintaining bactericidal activity.
Solution Approach 2:
The patent optimizes different regions of the peptide sequence for specific functions: the N-terminus may be designed for high stability against proteases, while the C-terminus contains the hydrophobic core responsible for membrane disruption. This local differentiation of functional properties allows the peptide to maintain stability in the environment while retaining high bactericidal efficacy.
Data Source
AI summary
Antimicrobial compositions having bactericidal activity are described. Also described is a method of treating bacterial infections using compositions comprising antimicrobial peptides or variants thereof.